Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura
Peyvandi, F., Scully, M., Kremer Hovinga, J. A., Knöbl, P., Cataland, S., De Beuf, K., Callewaert, F., De Winter, H., Zeldin, R. K.
Published in Journal of thrombosis and haemostasis (01.07.2017)
Published in Journal of thrombosis and haemostasis (01.07.2017)
Get full text
Journal Article
FRI0239 Results of a phase 2b study of vobarilizumab, an anti-interleukin-6 receptor nanobody, as monotherapy in patients with moderate to severe rheumatoid arthritis
Dörner, T, Weinblatt, M, Beneden, K Van, Dombrecht, EJ, Beuf, K De, Schoen, P, Zeldin, RK
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
OP0098 Remission and maintenance of efficacy in a phase 2b study of vobarilizumab, an anti-interleukin 6 receptor nanobody, in patients with moderate-to-severe rheumatoid arthritis despite treatment with methotrexate
Dörner, T, Weinblatt, M, Durez, P, Alten, R, Beneden, K Van, Dombrecht, EJ, Beuf, K De, Schoen, P, Zeldin, RK
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
Seasonality modifies the effect of a lipid-based nutrient supplement for pregnant rural women on birth length
Toe, L.C.; Bouckaert, K. P.; De Beuf, K.; Roberfroid, Dominique; Meda, N.; Thas, O.; Van Camp, J.; Kolsteren, Patrick; Huybregts, Lieven F
Year of Publication 30.01.2015
Get more information
Year of Publication 30.01.2015
Journal Article